Recent News

By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.

The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.

The pictures provide new clues about how the androgen receptor interacts with cancer-causing proteins.

Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.

The in-person event featured scientific talks from leading women in science, including winners of this year’s Kravis WiSE fellowships.

Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.

Sloan Kettering Institute scientists are using zebrafish to understand human skin cancer that attacks the hands and feet.

The results of this collaborative project overturn some conventional wisdom about how the DNA repair process works.

With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought.

Paige Arnold, a graduate student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), is one of 13 PhD candidates selected from around the world to receive a Harold M. Weintraub Graduate Student Award for the quality, originality, and significance of their doctoral research.